Schimenti
My lab studies mechanisms of genome maintenance and consequences of genome instability. Such consequences include cancer, cellular senescence, impacts on stem cells, and lethal levels of inflammation.
My lab studies mechanisms of genome maintenance and consequences of genome instability. Such consequences include cancer, cellular senescence, impacts on stem cells, and lethal levels of inflammation.
(1) Histone functional genetic models to study epigenetic regulation of mouse hematopoiesis and immune cell development. (2) Mechanisms and function of epigenetic memory of inflammation in hematopoietic stem cells. (3) “Signaling to chromatin” and ...
Read More
There is a fine balance between appropriate, host-protective, immune responses and dysregulated autoimmune and pathologic inflammation. The Leifer lab investigates how immune responses are induced and regulated with the hope of developing treatments to ...
Read More
My lab is currently focused on two areas of immunology, canine immune mediated disease and aging of the immune system. We are particularly interested in identifying mechanistic biomarkers to help improve, diagnosis, prognosis and ...
Read More
My research focuses on deciphering the role of exosomes in mediating the crosstalk between the host immune system and the tumor, and the mechanisms through which exosomes coax the immune system to contribute to ...
Read More
Nutrition, infection, and inflammation in pregnancy Role of key micronutrients (iron, vitamin B12, folate) in the etiology of adverse perinatal outcomes (including anemia, infections, birth defects) Design of interventions to improve the health of ...
Read More
We are interested in the genetic and environmental factors that regulate regulatory lymphocyte development and function, and how they interact to regulate immune homeostasis.
We are interested in understanding the impact of the gut microbiome, a vast population of microorganisms that inhabits our intestines, in regulating many aspects of human health and disease. To accomplish these goals, our ...
Read More
New biodegradable biomaterials for a variety of biomedical applications like wound healing, drug delivery etc. Design and develop new tunable immune-responsive biomaterials to control macrophage phenotype for achieving desirable clinical outcomes.
We are interested in the role of Tyrosine Kinases (TKs) in regulating the immune response, with the goal of using this information to manipulate immune responses. We are specifically interested in the Tec families ...
Read More